Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

346 results
  1. ... Central Nervous System Tumors by Tumor Type section. References Mehta M, Vogelbaum MA, Chang S, et al.: ... with defined chromosomal abnormalities are associated with gliomas. References Kleihues P, Cavenee WK, eds.: Pathology and Genetics ...
  2. ... asymmetry, border irregularity, color variation, and large diameter. References Vandergriff TW, Bergstresser PR: Anatomy and physiology. In: ... treatment was discontinued. Level of evidence (vismodegib): 3diii References Miller DL, Weinstock MA: Nonmelanoma skin cancer in ...
  3. ... of initial response to leukemic induction therapy.[ 9 ] References Arber DA, Orazi A, Hasserjian RP, et al.: ... General information about clinical trials is also available. References Arber DA, Orazi A, Hasserjian RP, et al.: ...
  4. ... available, it is summarized under its own heading. References Larkin PJ, Cherny NI, La Carpia D, et ... General information about clinical trials is also available. References Lindberg G, Hamid SS, Malfertheiner P, et al.: ...
  5. ... 2009. Published by Wiley-Blackwell. All rights reserved. References Toker C: Trabecular carcinoma of the skin. Arch ... American Society of Clinical Oncology. All rights reserved. References Nghiem P, McKee PH, Haynes HA: Merkel cell ( ...
  6. ... the third year, and every 6 months thereafter. References American Cancer Society: Cancer Facts and Figures 2024. ... and Peripheral T-Cell Non-Hodgkin Lymphoma Treatment . References Mendenhall WM, Werning JW, Pfister DG: Treatment of ...
  7. ... are a mild laxative effect and gastrointestinal upset. References PDR® for Herbal Medicines™. 2nd ed. Medical Economics, ... supportive therapy for chronic inflammatory liver conditions.[ 3 ] References Flora K, Hahn M, Rosen H, et al.: ...
  8. ... the BCR :: ABL1 fusion gene during TKI therapy. References Ries LA, Smith MA, Gurney JG, et al., ... high risk in the chronic phase.[ 2 , 3 ] References Quintás-Cardama A, Cortes J: Molecular biology of ...
  9. ... appropriate cytoreductive therapy, and the transplant conditioning regimen. References Arber DA, Orazi A, Hasserjian RP, et al.: ... are likely due to unknown disease-modifying factors. References Alter BP, Giri N, Savage SA, et al.: ...
  10. ... the pancreas. Pancreatoblastoma. Islet cell tumor. Pancreatic carcinoma. References Chung EM, Travis MD, Conran RM: Pancreatic tumors ... and Pancreatic Neuroendocrine Tumors (Islet Cell Tumors) Treatment . References Smith MA, Seibel NL, Altekruse SF, et al.: ...
first · previous · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · next · last